AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 185 filers reported holding AMYLYX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $32,000 | +966.7% | 17,131 | +1167.1% | 0.00% | – |
| Q1 2024 | $3,000 | -98.7% | 1,352 | -91.6% | 0.00% | – |
| Q4 2023 | $237,000 | +60.1% | 16,155 | +99.6% | 0.00% | – |
| Q3 2023 | $148,000 | +68.2% | 8,095 | +98.7% | 0.00% | – |
| Q2 2023 | $88,000 | -17.8% | 4,074 | +12.3% | 0.00% | – |
| Q1 2023 | $107,000 | -56.7% | 3,628 | -45.7% | 0.00% | – |
| Q4 2022 | $247,000 | +550.0% | 6,677 | +386.3% | 0.00% | – |
| Q3 2022 | $38,000 | +100.0% | 1,373 | +36.2% | 0.00% | – |
| Q2 2022 | $19,000 | -66.1% | 1,008 | -76.5% | 0.00% | – |
| Q1 2022 | $56,000 | – | 4,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
| Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
| GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
| Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
| Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
| Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
| Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
| SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
| AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |